Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Ferraroni

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|July 12, 2023
First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency SyndromeAndrea Angeli, Marta Ferraroni, Carlotta Granchi, et al.
Journal of Medicinal Chemistry|November 27, 2025
Targeting Human Carbonic Anhydrases with Novel Piperazine and Homopiperazine Benzenesulfonamides to Alleviate Paclitaxel-Induced Peripheral NeuropathyLaura Micheli, Andrea Angeli, Lorenzo Di Cesare Mannelli, et al.
Journal of Medicinal Chemistry|October 14, 2014
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groupsMurat Bozdag, Marta Ferraroni, Fabrizio Carta, et al.
Journal of Agricultural and Food Chemistry|May 11, 2025
Molecular Basis of <i>Pseudomonas syringae</i> pv <i>actinidiae</i> Levansucrase Inhibition by a Multivalent IminosugarCostanza Cicchi, Luigia Pazzagli, Paolo Paoli, et al.
Bioorganic Chemistry|August 3, 2019
Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitorsNiccolò Chiaramonte, Silvia Bua, Andrea Angeli, et al.
Journal of Medicinal Chemistry|January 8, 2016
4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic StudiesBenedetta Cornelio, Marie Laronze-Cochard, Mariangela Ceruso, et al.
Journal of Medicinal Chemistry|January 24, 2024
Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma TherapyAndrea Angeli, Irene Chelli, Laura Lucarini, et al.
European Journal of Medicinal Chemistry|September 10, 2025
Dual inhibition of carbonic anhydrase IX and glutathione peroxidase 4 as a novel strategy for ferroptosis-induced tumor cell deathGioele Renzi, Paul C McDonald, Shannon Awrey, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2016
Anion inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio choleraeDaniela Vullo, Sonia Del Prete, Viviana De Luca, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory PainElena Lucarini, Vanessa D'Antogiovanni, Luca Antonioli, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|July 12, 2023
First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency SyndromeAndrea Angeli, Marta Ferraroni, Carlotta Granchi, et al.
Journal of Medicinal Chemistry|November 27, 2025
Targeting Human Carbonic Anhydrases with Novel Piperazine and Homopiperazine Benzenesulfonamides to Alleviate Paclitaxel-Induced Peripheral NeuropathyLaura Micheli, Andrea Angeli, Lorenzo Di Cesare Mannelli, et al.
Journal of Medicinal Chemistry|October 14, 2014
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groupsMurat Bozdag, Marta Ferraroni, Fabrizio Carta, et al.
Journal of Agricultural and Food Chemistry|May 11, 2025
Molecular Basis of <i>Pseudomonas syringae</i> pv <i>actinidiae</i> Levansucrase Inhibition by a Multivalent IminosugarCostanza Cicchi, Luigia Pazzagli, Paolo Paoli, et al.
Bioorganic Chemistry|August 3, 2019
Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitorsNiccolò Chiaramonte, Silvia Bua, Andrea Angeli, et al.
Journal of Medicinal Chemistry|January 8, 2016
4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic StudiesBenedetta Cornelio, Marie Laronze-Cochard, Mariangela Ceruso, et al.
Journal of Medicinal Chemistry|January 24, 2024
Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma TherapyAndrea Angeli, Irene Chelli, Laura Lucarini, et al.
European Journal of Medicinal Chemistry|September 10, 2025
Dual inhibition of carbonic anhydrase IX and glutathione peroxidase 4 as a novel strategy for ferroptosis-induced tumor cell deathGioele Renzi, Paul C McDonald, Shannon Awrey, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2016
Anion inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio choleraeDaniela Vullo, Sonia Del Prete, Viviana De Luca, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory PainElena Lucarini, Vanessa D'Antogiovanni, Luca Antonioli, et al.
Pageof 12